BG104385A - Physiologically acceptable aqueous solutions and methods for their application - Google Patents

Physiologically acceptable aqueous solutions and methods for their application

Info

Publication number
BG104385A
BG104385A BG104385A BG10438500A BG104385A BG 104385 A BG104385 A BG 104385A BG 104385 A BG104385 A BG 104385A BG 10438500 A BG10438500 A BG 10438500A BG 104385 A BG104385 A BG 104385A
Authority
BG
Bulgaria
Prior art keywords
methods
application
aqueous solutions
physiologically acceptable
acceptable aqueous
Prior art date
Application number
BG104385A
Other languages
Bulgarian (bg)
Inventor
Paul Segall
Hal Sternberg
Harold Waitz
Judith Segall
Original Assignee
Biotime, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime, Inc filed Critical Biotime, Inc
Publication of BG104385A publication Critical patent/BG104385A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The solutions are used in cases where at least part of the blood volume of the recipient is replaced by blood substituent. They contain electrolytes, dynamic buffering system and an oncotic agent in the absence of the customary biological buffer. 16 claims
BG104385A 1997-10-31 2000-04-27 Physiologically acceptable aqueous solutions and methods for their application BG104385A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/019964 WO1999022746A1 (en) 1997-10-31 1997-10-31 Physiologically acceptable aqueous solutions and methods for their use

Publications (1)

Publication Number Publication Date
BG104385A true BG104385A (en) 2000-12-29

Family

ID=22261994

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104385A BG104385A (en) 1997-10-31 2000-04-27 Physiologically acceptable aqueous solutions and methods for their application

Country Status (9)

Country Link
AU (1) AU5102698A (en)
BG (1) BG104385A (en)
CZ (1) CZ294795B6 (en)
HU (1) HUP0004094A3 (en)
SK (1) SK6282000A3 (en)
TR (1) TR200001187T2 (en)
TW (1) TW562678B (en)
UA (1) UA72449C2 (en)
WO (1) WO1999022746A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996001118A1 (en) 1994-07-01 1996-01-18 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
US9237744B2 (en) * 2004-05-26 2016-01-19 National University Corporation Kagawa University Preservative solution for cells, tissues and organs containing rare sugar and preservative method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414815A1 (en) * 1988-05-02 1991-03-06 Cryomedical Sciences, Inc. Blood substitute
DK0437274T3 (en) * 1990-01-12 1994-10-10 Bartz Volker Bicarbonate- and calcium-containing infusion and dialysis solution
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
EP0701455B1 (en) * 1993-06-04 2001-03-14 Biotime, Inc. Plasma-like solution
AU4526996A (en) * 1994-12-28 1996-07-19 Biotime, Inc. Plasma expanders and blood substitutes

Also Published As

Publication number Publication date
HUP0004094A3 (en) 2001-04-28
TR200001187T2 (en) 2000-08-21
CZ20001531A3 (en) 2000-10-11
CZ294795B6 (en) 2005-03-16
TW562678B (en) 2003-11-21
WO1999022746A1 (en) 1999-05-14
AU5102698A (en) 1999-05-24
HUP0004094A2 (en) 2001-03-28
SK6282000A3 (en) 2001-02-12
UA72449C2 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
BR9713866A (en) Pharmaceutical composition
MXPA02010971A (en) High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa .
MX9805628A (en) Novel cycloalkyl substituted imidazoles.
GR3034069T3 (en) Decontaminating blood components with 8-methoxypsoralen.
AU2525401A (en) Use of an extract of at least one vaccinium-type plant as an anti-glycation agent
GB9822440D0 (en) Medicaments
AU6825300A (en) Compounds
AU6564794A (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
MX9710206A (en) Pharmaceutical amiodarone composition for parenteral delivery.
AU7492100A (en) Architecture, method(s) and circuitry for low power memories
IT1261695B (en) USE OF L-CARNITINE AND ALCANOIL L-CARNITINE IN THE PRESERVATION OF BLOOD FOR TRANSFUSIONS AND STABILIZING SOLUTIONS THAT CONTAIN THEM.
MY125622A (en) Buffered compositions for dialysis
AU2197195A (en) Mos circuit with dynamically reduced threshold voltage, as for use in an output buffer of a hearing aid amplifier
DE60003943D1 (en) TRIMEGESTONE CONTAINING PHARMACEUTICAL COMPOSITIONS
BG104385A (en) Physiologically acceptable aqueous solutions and methods for their application
GB9905663D0 (en) Iodine preparation composition
EP0367271A3 (en) Improved red blood cell preservative solution
MX9805939A (en) Solid instant-release forms of administration and process for producing the same.
AU6076500A (en) Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents
IL139283A0 (en) Dextrin-containing composition for preventing surgical adhesions
NO971604L (en) Oral sabeluzole suspensions
NZ504194A (en) Physiologically acceptable aqueous solutions and methods for their use
AU4544600A (en) Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
PL356240A1 (en) Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
CA2250844A1 (en) Anti-hiv composition comprising imidazole derivatives